Around US$ 1207.3 million is projected to be the value of global sales of gastroesophageal reflux disease (GERD) device in 2024. By 2034, the gastroesophageal reflux disease (GERD) device market is anticipated to advance at a 3.6% CAGR and surpass a valuation of US$ 1719.5 million. The increasing prevalence of GERD and the development of less invasive treatment options are projected to contribute to the gastroesophageal reflux disease device market's steady rise.
Technological advancements such as endoscopic therapy and magnetic sphincter augmentation devices are becoming a growing trend since they provide efficient substitutes for conventional surgical and pharmaceutical methods. The gastroesophageal reflux disease (GERD) device market is expanding due to patients and healthcare professionals becoming conscious of the advantages of these devices, which include quicker recovery times and enhanced quality of life.
Attributes | Details |
---|---|
Market Value for 2024 | US$ 1207.3 million |
Market Value for 2034 | US$ 1719.5 million |
Market CAGR from 2024 to 2034 | 3.6% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Attributes | Details |
---|---|
Market Value for 2019 | US$ 1001 million |
Market Value for 2023 | US$ 1213.4 million |
Market CAGR from 2019 to 2023 | 3.9% |
The gastroesophageal reflux disease therapeutics market and the medical device technologies market have both been studied by Future Market Insights (FMI). The data depict the projected growth of the GERD device market from 2024 to 2034 in other markets. It showcases the potential for revenue in the additional markets shown below.
Gastroesophageal Reflux Disease (GERD) Device Market:
Attributes | Gastroesophageal Reflux Disease (GERD) Device Market |
---|---|
Value-based CAGR (2024 to 2034) | 3.6% |
Growth Factor | The gastroesophageal reflux disease (GERD) device market is growing due to increased demand for less intrusive GERD therapies. |
Market Trend | Modern anti-reflux gadgets advance market growth of gastroesophageal reflux disease (GERD) device. |
Market Restraint | The broader adoption of gastroesophageal reflux disease (GERD) devices is hampered by limited insurance coverage. |
Gastroesophageal Reflux Disease Therapeutics Market:
Attributes | Gastroesophageal Reflux Disease Therapeutics Market |
---|---|
Value-based CAGR (2024 to 2034) | 3% |
Growth Factor | Globally, the prevalence of gastroesophageal reflux diseases is rising. |
Market Trend | An aging population is one factor raising the occurrence of gastroesophageal reflux diseases. |
Market Restraint | Patent expirations impose pressure on prices and generic competition. |
Medical Device Technologies Market:
Attributes | Medical Device Technologies Market |
---|---|
Value-based CAGR (2024 to 2034) | 6.4% |
Growth Factor | An increase in the prevalence of chronic illnesses calls for the growth of novel medical device technologies. |
Market Trend | Switch toward value-based healthcare models that provide remote monitoring and preventative care. |
Market Restraint | Growing concerns about cybersecurity and data privacy in connected medical equipment. |
The segmented study of the gastroesophageal reflux disease (GERD) device market is detailed in the part below. Extensive research demonstrates that diagnostic procedures are at the forefront of procedural innovations, with esophagoscopes and gastroscopes commanding the product segment.
This comprehensive analysis sheds light on the constantly shifting landscape of GERD management, identifying major trends and in the gastroesophageal reflux disease device market.
Segment | Esophagoscopes and Gastroscopes |
---|---|
Share (2024) | 90% |
Segment | Diagnostic Procedures |
---|---|
Share (2024) | 68% |
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The GERD device market can be observed in the subsequent tables, which focus on the leading regions in North America, Europe, and Asia Pacific. A comprehensive evaluation demonstrates that Asia Pacific has enormous market opportunities for gastroesophageal reflux disease device.
Opportunities in the Asia Pacific Gastroesophageal Reflux Disease (GERD) Device Industry
Countries | CAGR (2024 to 2034) |
---|---|
India | 5.2% |
Thailand | 5.0% |
Malaysia | 4.6% |
Indonesia | 3.4% |
Insights into Sales Performance of Gastroesophageal Reflux Disease (GERD) Device in North America
Countries | CAGR (2024 to 2034) |
---|---|
United States | 2.6% |
Canada | 2.9% |
Opportunities for Gastroesophageal Reflux Disease (GERD) Device Market in Europe
Countries | CAGR (2024 to 2034) |
---|---|
Germany | 1.9% |
United Kingdom | 1.6% |
France | 2.3% |
Italy | 2.0% |
Spain | 2.9% |
Several prominent gastroesophageal reflux disease device vendors are vying for market share in the highly competitive atmosphere of the industry.
Notable gastroesophageal reflux disease device manufacturers influencing the direction of the business are Olympus Corporation, Pentax Medical, KARL STORZ SE & Co KG, Medtronic Plc, Fujifilm Holdings Corporation, EndoGastric Solutions, Medigus Ltd., and Diversatek Inc. By addressing the difficulties associated with managing GERD, these gastroesophageal reflux disease device businesses offer a variety of technological expertise, creating a competitive atmosphere centered on enhancing patient outcomes and expanding available treatment options.
Olympus Corporation, Pentax Medical, KARL STORZ SE, and Co KG are improving GERD device technology. This gastroesophageal reflux disease (GERD) device providers are known for their dedication to quality and innovation. Medtronic Plc uses its broad healthcare portfolio to provide comprehensive solutions for managing GERD, while Fujifilm Holdings Corporation contributes its imaging expertise to improve diagnostic capabilities.
By providing specialized tools and methods that address particular patient demands and broaden the range of available treatments, EndoGastric Solutions, Medigus Ltd., and Diversatek Inc. make contributions.
Continuous innovation and development in GERD management tactics are expected as these major gastroesophageal reflux disease device vendors cooperate and compete. These gastroesophageal reflux disease device suppliers are essential in influencing the direction of GERD therapy and enhancing the lives of those impacted by the disease by emphasizing patient-centric solutions and technical innovations.
Notable Strides
Company | Details |
---|---|
Wockhardt Ltd. | Wockhardt Ltd. acquired its authorized generic versions of several over-the-counter medications from Glenmark Pharmaceuticals Ltd. in June 2022. The approved abbreviated new drug applications for famotidine tablets, which are used to treat and prevent stomach and intestinal ulcers, as well as treatment drug Lansoprazole delayed-release capsules USP, 15 mg, are among the medications included in the acquisition by the company's fully owned subsidiary Glenmark Pharmaceuticals Inc, USA. |
Zydus Lifesciences | The FDA approved Zydus Lifesciences' 20 mg and 40 mg formulations of metronidazole tablets for sale in June 2022. As a histamine H2 receptor blocker, famotidine lowers stomach acid production. The medication is intended to treat and prevent acid reflux disease (GERD) as well as other related symptoms. |
Peptest | Peptest, a non-invasive radiofrequency device designed by RD Biomed for the diagnosis of reflux devices, was approved by China. This device detects pepsin in saliva samples and helps with the overall treatment of reflux-related devices. |
EsophyX Z | An improved and more recent version of the EsophyX device is the EsophyX Z gastroesophageal reflux disease device, used to perform transoral incisionless fundoplication. |
The GERD device market to secure a valuation US$ 1207.3 million in 2024.
The GERD device market is estimated to attain US$ 1719.5 million by 2034.
Through 2034, the GERD device market is anticipated to evolve at a 3.6% CAGR.
From 2019 to 2023, the gastroesophageal reflux disease (GERD) device market registered a 3.9% CAGR.
The esophagoscopes and gastroscopes sector is set to achieve a market share of 90% in 2024.
A 68% market share is expected for the diagnostic procedures sector in 2024.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Product Life Cycle Analysis 3.5. Supply Chain Analysis 3.5.1. Supply Side Participants and their Roles 3.5.1.1. Manufacturer 3.5.1.2. Mid-Level Participants (Traders) 3.5.1.3. Distributors 3.5.2. Value Added and Value Created at Node in the Supply Chain 3.5.3. List of Raw Material Suppliers 3.5.4. List of Existing and Potential Buyer’s 3.6. Investment Feasibility Matrix 3.7. Value Chain Analysis 3.7.1. Profit Margin Analysis 3.7.2. Distributors 3.8. PESTLE and Porter’s Analysis 3.9. Regulatory Landscape 3.9.1. By Key Regions 3.9.2. By Key Countries 3.10. Regional Parent Market Outlook 3.11. Production and Consumption Statistics 3.12. Import and Export Statistics 4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034 4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2019 to 2023 4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2024 to 2034 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Product 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Product, 2019 to 2023 5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Product, 2024 to 2034 5.3.1. Diagnostic Devices 5.3.2. Manometry Systems 5.3.3. PH Monitoring Systems 5.3.4. Esophagoscopes and Gastroscopes 5.3.5. Treatment Devices 5.3.6. Ultrasonic Surgical Endostaplers 5.3.7. Fundoplication Devices 5.3.8. Sphincter Augmentation Devices 5.3.9. Radiofrequency Ablation Devices 5.4. Y-o-Y Growth Trend Analysis By Product, 2019 to 2023 5.5. Absolute $ Opportunity Analysis By Product, 2024 to 2034 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Procedure 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Procedure, 2019 to 2023 6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Procedure, 2024 to 2034 6.3.1. Diagnostic Procedures 6.3.2. Fundoplication Procedures 6.3.3. Radiofrequency Thermal Ablation 6.3.4. Magnetic Sphincter Augmentation 6.4. Y-o-Y Growth Trend Analysis By Procedure, 2019 to 2023 6.5. Absolute $ Opportunity Analysis By Procedure, 2024 to 2034 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End User 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By End User, 2019 to 2023 7.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By End User, 2024 to 2034 7.3.1. Hospitals 7.3.2. Diagnostic Centers 7.3.3. Ambulatory Surgical Centers 7.4. Y-o-Y Growth Trend Analysis By End User, 2019 to 2023 7.5. Absolute $ Opportunity Analysis By End User, 2024 to 2034 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region 8.1. Introduction 8.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2019 to 2023 8.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2024 to 2034 8.3.1. North America 8.3.2. Latin America 8.3.3. Western Europe 8.3.4. Eastern Europe 8.3.5. South Asia and Pacific 8.3.6. East Asia 8.3.7. Middle East and Africa 8.4. Market Attractiveness Analysis By Region 9. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 9.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023 9.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034 9.2.1. By Country 9.2.1.1. USA 9.2.1.2. Canada 9.2.2. By Product 9.2.3. By Procedure 9.2.4. By End User 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Product 9.3.3. By Procedure 9.3.4. By End User 9.4. Key Takeaways 10. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023 10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034 10.2.1. By Country 10.2.1.1. Brazil 10.2.1.2. Mexico 10.2.1.3. Rest of Latin America 10.2.2. By Product 10.2.3. By Procedure 10.2.4. By End User 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Product 10.3.3. By Procedure 10.3.4. By End User 10.4. Key Takeaways 11. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023 11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034 11.2.1. By Country 11.2.1.1. Germany 11.2.1.2. UK 11.2.1.3. France 11.2.1.4. Spain 11.2.1.5. Italy 11.2.1.6. Rest of Western Europe 11.2.2. By Product 11.2.3. By Procedure 11.2.4. By End User 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Product 11.3.3. By Procedure 11.3.4. By End User 11.4. Key Takeaways 12. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023 12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034 12.2.1. By Country 12.2.1.1. Poland 12.2.1.2. Russia 12.2.1.3. Czech Republic 12.2.1.4. Romania 12.2.1.5. Rest of Eastern Europe 12.2.2. By Product 12.2.3. By Procedure 12.2.4. By End User 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Product 12.3.3. By Procedure 12.3.4. By End User 12.4. Key Takeaways 13. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023 13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034 13.2.1. By Country 13.2.1.1. India 13.2.1.2. Bangladesh 13.2.1.3. Australia 13.2.1.4. New Zealand 13.2.1.5. Rest of South Asia and Pacific 13.2.2. By Product 13.2.3. By Procedure 13.2.4. By End User 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Product 13.3.3. By Procedure 13.3.4. By End User 13.4. Key Takeaways 14. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023 14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034 14.2.1. By Country 14.2.1.1. China 14.2.1.2. Japan 14.2.1.3. South Korea 14.2.2. By Product 14.2.3. By Procedure 14.2.4. By End User 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Product 14.3.3. By Procedure 14.3.4. By End User 14.4. Key Takeaways 15. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 15.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023 15.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034 15.2.1. By Country 15.2.1.1. GCC Countries 15.2.1.2. South Africa 15.2.1.3. Israel 15.2.1.4. Rest of MEA 15.2.2. By Product 15.2.3. By Procedure 15.2.4. By End User 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Product 15.3.3. By Procedure 15.3.4. By End User 15.4. Key Takeaways 16. Key Countries Market Analysis 16.1. USA 16.1.1. Pricing Analysis 16.1.2. Market Share Analysis, 2023 16.1.2.1. By Product 16.1.2.2. By Procedure 16.1.2.3. By End User 16.2. Canada 16.2.1. Pricing Analysis 16.2.2. Market Share Analysis, 2023 16.2.2.1. By Product 16.2.2.2. By Procedure 16.2.2.3. By End User 16.3. Brazil 16.3.1. Pricing Analysis 16.3.2. Market Share Analysis, 2023 16.3.2.1. By Product 16.3.2.2. By Procedure 16.3.2.3. By End User 16.4. Mexico 16.4.1. Pricing Analysis 16.4.2. Market Share Analysis, 2023 16.4.2.1. By Product 16.4.2.2. By Procedure 16.4.2.3. By End User 16.5. Germany 16.5.1. Pricing Analysis 16.5.2. Market Share Analysis, 2023 16.5.2.1. By Product 16.5.2.2. By Procedure 16.5.2.3. By End User 16.6. UK 16.6.1. Pricing Analysis 16.6.2. Market Share Analysis, 2023 16.6.2.1. By Product 16.6.2.2. By Procedure 16.6.2.3. By End User 16.7. France 16.7.1. Pricing Analysis 16.7.2. Market Share Analysis, 2023 16.7.2.1. By Product 16.7.2.2. By Procedure 16.7.2.3. By End User 16.8. Spain 16.8.1. Pricing Analysis 16.8.2. Market Share Analysis, 2023 16.8.2.1. By Product 16.8.2.2. By Procedure 16.8.2.3. By End User 16.9. Italy 16.9.1. Pricing Analysis 16.9.2. Market Share Analysis, 2023 16.9.2.1. By Product 16.9.2.2. By Procedure 16.9.2.3. By End User 16.10. Poland 16.10.1. Pricing Analysis 16.10.2. Market Share Analysis, 2023 16.10.2.1. By Product 16.10.2.2. By Procedure 16.10.2.3. By End User 16.11. Russia 16.11.1. Pricing Analysis 16.11.2. Market Share Analysis, 2023 16.11.2.1. By Product 16.11.2.2. By Procedure 16.11.2.3. By End User 16.12. Czech Republic 16.12.1. Pricing Analysis 16.12.2. Market Share Analysis, 2023 16.12.2.1. By Product 16.12.2.2. By Procedure 16.12.2.3. By End User 16.13. Romania 16.13.1. Pricing Analysis 16.13.2. Market Share Analysis, 2023 16.13.2.1. By Product 16.13.2.2. By Procedure 16.13.2.3. By End User 16.14. India 16.14.1. Pricing Analysis 16.14.2. Market Share Analysis, 2023 16.14.2.1. By Product 16.14.2.2. By Procedure 16.14.2.3. By End User 16.15. Bangladesh 16.15.1. Pricing Analysis 16.15.2. Market Share Analysis, 2023 16.15.2.1. By Product 16.15.2.2. By Procedure 16.15.2.3. By End User 16.16. Australia 16.16.1. Pricing Analysis 16.16.2. Market Share Analysis, 2023 16.16.2.1. By Product 16.16.2.2. By Procedure 16.16.2.3. By End User 16.17. New Zealand 16.17.1. Pricing Analysis 16.17.2. Market Share Analysis, 2023 16.17.2.1. By Product 16.17.2.2. By Procedure 16.17.2.3. By End User 16.18. China 16.18.1. Pricing Analysis 16.18.2. Market Share Analysis, 2023 16.18.2.1. By Product 16.18.2.2. By Procedure 16.18.2.3. By End User 16.19. Japan 16.19.1. Pricing Analysis 16.19.2. Market Share Analysis, 2023 16.19.2.1. By Product 16.19.2.2. By Procedure 16.19.2.3. By End User 16.20. South Korea 16.20.1. Pricing Analysis 16.20.2. Market Share Analysis, 2023 16.20.2.1. By Product 16.20.2.2. By Procedure 16.20.2.3. By End User 16.21. GCC Countries 16.21.1. Pricing Analysis 16.21.2. Market Share Analysis, 2023 16.21.2.1. By Product 16.21.2.2. By Procedure 16.21.2.3. By End User 16.22. South Africa 16.22.1. Pricing Analysis 16.22.2. Market Share Analysis, 2023 16.22.2.1. By Product 16.22.2.2. By Procedure 16.22.2.3. By End User 16.23. Israel 16.23.1. Pricing Analysis 16.23.2. Market Share Analysis, 2023 16.23.2.1. By Product 16.23.2.2. By Procedure 16.23.2.3. By End User 17. Market Structure Analysis 17.1. Competition Dashboard 17.2. Competition Benchmarking 17.3. Market Share Analysis of Top Players 17.3.1. By Regional 17.3.2. By Product 17.3.3. By Procedure 17.3.4. By End User 18. Competition Analysis 18.1. Competition Deep Dive 18.1.1. Olympus Corporation 18.1.1.1. Overview 18.1.1.2. Product Portfolio 18.1.1.3. Profitability by Market Segments 18.1.1.4. Sales Footprint 18.1.1.5. Strategy Overview 18.1.1.5.1. Marketing Strategy 18.1.1.5.2. Product Strategy 18.1.1.5.3. Channel Strategy 18.1.2. Pentax Medical 18.1.2.1. Overview 18.1.2.2. Product Portfolio 18.1.2.3. Profitability by Market Segments 18.1.2.4. Sales Footprint 18.1.2.5. Strategy Overview 18.1.2.5.1. Marketing Strategy 18.1.2.5.2. Product Strategy 18.1.2.5.3. Channel Strategy 18.1.3. KARL STORZ SE & Co KG. 18.1.3.1. Overview 18.1.3.2. Product Portfolio 18.1.3.3. Profitability by Market Segments 18.1.3.4. Sales Footprint 18.1.3.5. Strategy Overview 18.1.3.5.1. Marketing Strategy 18.1.3.5.2. Product Strategy 18.1.3.5.3. Channel Strategy 18.1.4. Medtronic Plc 18.1.4.1. Overview 18.1.4.2. Product Portfolio 18.1.4.3. Profitability by Market Segments 18.1.4.4. Sales Footprint 18.1.4.5. Strategy Overview 18.1.4.5.1. Marketing Strategy 18.1.4.5.2. Product Strategy 18.1.4.5.3. Channel Strategy 18.1.5. Fujifilm Holdings Corporation 18.1.5.1. Overview 18.1.5.2. Product Portfolio 18.1.5.3. Profitability by Market Segments 18.1.5.4. Sales Footprint 18.1.5.5. Strategy Overview 18.1.5.5.1. Marketing Strategy 18.1.5.5.2. Product Strategy 18.1.5.5.3. Channel Strategy 18.1.6. EndoGastric Solutions 18.1.6.1. Overview 18.1.6.2. Product Portfolio 18.1.6.3. Profitability by Market Segments 18.1.6.4. Sales Footprint 18.1.6.5. Strategy Overview 18.1.6.5.1. Marketing Strategy 18.1.6.5.2. Product Strategy 18.1.6.5.3. Channel Strategy 18.1.7. Medigus Ltd. 18.1.7.1. Overview 18.1.7.2. Product Portfolio 18.1.7.3. Profitability by Market Segments 18.1.7.4. Sales Footprint 18.1.7.5. Strategy Overview 18.1.7.5.1. Marketing Strategy 18.1.7.5.2. Product Strategy 18.1.7.5.3. Channel Strategy 18.1.8. Diversatek Inc. 18.1.8.1. Overview 18.1.8.2. Product Portfolio 18.1.8.3. Profitability by Market Segments 18.1.8.4. Sales Footprint 18.1.8.5. Strategy Overview 18.1.8.5.1. Marketing Strategy 18.1.8.5.2. Product Strategy 18.1.8.5.3. Channel Strategy 18.1.9. LABORIE 18.1.9.1. Overview 18.1.9.2. Product Portfolio 18.1.9.3. Profitability by Market Segments 18.1.9.4. Sales Footprint 18.1.9.5. Strategy Overview 18.1.9.5.1. Marketing Strategy 18.1.9.5.2. Product Strategy 18.1.9.5.3. Channel Strategy 18.1.10. Mederi Therapeutics Inc. 18.1.10.1. Overview 18.1.10.2. Product Portfolio 18.1.10.3. Profitability by Market Segments 18.1.10.4. Sales Footprint 18.1.10.5. Strategy Overview 18.1.10.5.1. Marketing Strategy 18.1.10.5.2. Product Strategy 18.1.10.5.3. Channel Strategy 19. Assumptions & Acronyms Used 20. Research Methodology
Healthcare
March 2023
REP-GB-16787
301 pages
Explore Healthcare Insights
View Reports